Literature DB >> 8820796

Tolerability of topical NSAIDs in the elderly: do they really convey a safety advantage?

J M Evans1, T M MacDonald.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are very widely prescribed but they have a poor tolerability profile, with a range of potential adverse effects. NSAIDs that are used in topical formulations have been developed in the past 15 years and their use is increasing. The purpose is to achieve a high local concentration of the active ingredient at the affected site, with as low a plasma concentration as possible to minimise possible systemic adverse effects. The gastrointestinal and renal toxicity of topical NSAIDs has recently been highlighted in the medical literature. The elderly seem to be more sensitive to the adverse effects of NSAIDs than younger individuals, and this may also be true for topical NSAIDs. More formal epidemiological evaluation of the safety of topical NSAIDs is required in the postmarketing situation, as the main source of information regarding adverse drug reactions to topical NSAIDs in the UK has been spontaneous reporting data.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8820796     DOI: 10.2165/00002512-199609020-00005

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  49 in total

1.  The yellow card: mark II.

Authors:  J P Griffin
Journal:  BMJ       Date:  1991-01-05

2.  Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs.

Authors:  L A García Rodríguez; H Jick
Journal:  Lancet       Date:  1994-03-26       Impact factor: 79.321

3.  Is research into the treatment of osteoarthritis with non-steroidal anti-inflammatory drugs misdirected?

Authors:  P A Dieppe; S J Frankel; B Toth
Journal:  Lancet       Date:  1993-02-06       Impact factor: 79.321

4.  Percutaneous treatment of acute soft tissue lesions with naproxen gel and ketoprofen gel.

Authors:  F Baixauli; F Inglés; P Alcántara; R Navarrete; E Puchol; F Vidal
Journal:  J Int Med Res       Date:  1990 Sep-Oct       Impact factor: 1.671

5.  Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis.

Authors:  A G Johnson; T V Nguyen; R O Day
Journal:  Ann Intern Med       Date:  1994-08-15       Impact factor: 25.391

6.  Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure.

Authors:  J M Evans; E McGregor; A D McMahon; M M McGilchrist; M C Jones; G White; D G McDevitt; T M MacDonald
Journal:  QJM       Date:  1995-08

7.  Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration.

Authors:  C P Armstrong; A L Blower
Journal:  Gut       Date:  1987-05       Impact factor: 23.059

8.  Examining product risk in context. Market withdrawal of zomepirac as a case study.

Authors:  D Ross-Degnan; S B Soumerai; E E Fortess; J H Gurwitz
Journal:  JAMA       Date:  1993-10-27       Impact factor: 56.272

9.  Initiation of antihypertensive treatment during nonsteroidal anti-inflammatory drug therapy.

Authors:  J H Gurwitz; J Avorn; R L Bohn; R J Glynn; M Monane; H Mogun
Journal:  JAMA       Date:  1994-09-14       Impact factor: 56.272

Review 10.  Transdermal non-steroidal anti-inflammatory agents.

Authors:  R Grahame
Journal:  Br J Clin Pract       Date:  1995 Jan-Feb
View more
  4 in total

Review 1.  Adverse effects of topical nonsteroidal antiinflammatory drugs in older adults with osteoarthritis: a systematic literature review.

Authors:  Una E Makris; Minna J Kohler; Liana Fraenkel
Journal:  J Rheumatol       Date:  2010-04-01       Impact factor: 4.666

Review 2.  Oral versus topical NSAIDs in rheumatic diseases: a comparison.

Authors:  C A Heyneman; C Lawless-Liday; G C Wall
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

3.  [Pulmonary infiltrates with blood eosinophilia in a 62-year-old patient].

Authors:  M Kohlhäufl; N Weber; A Morresi-Hauf; D Geiger; H Raith; K Häussinger
Journal:  Internist (Berl)       Date:  2003-08       Impact factor: 0.743

Review 4.  Topical Administration of Ibuprofen for Injured Athletes: Considerations, Formulations, and Comparison to Oral Delivery.

Authors:  Martin Anthony Christopher Manoukian; Christopher William Migdal; Amode Ravindra Tembhekar; Jerad Alexander Harris; Charles DeMesa
Journal:  Sports Med Open       Date:  2017-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.